FDA approves Pfizer’s new nasal spray treatment for migraines

The U.S. Food and Drug Administration has approved Pfizer’s newest drug on the migraine market, Zavzpret (zavegepant) — the first and only migraine treatment of its kind to be offered in nasal spray. The drug has shown in clinical trial…








